3.0.0 1040 2026-01-30T17:36:07Z 2026-01-30T17:36:07Z Senate S S 2025-03-13 119 https://www.congress.gov/bill/119th-congress/senate-bill/1040 ssju00 Judiciary Committee Senate Standing Reported By 2025-04-10T20:27:19Z Markup By 2025-04-03T14:15:02Z Referred To 2025-03-13T18:19:27Z 2025-04-10 Senate Placed on Senate Legislative Calendar under General Orders. Calendar No. 43. Calendars 2025-04-10 ssju00 Judiciary Committee Senate Committee on the Judiciary. Reported by Senator Grassley with an amendment. Without written report. Committee 2025-04-10 Committee on the Judiciary. Reported by Senator Grassley with an amendment. Without written report. Committee 14000 9 Library of Congress ssju00 Judiciary Committee 2025-04-03 ssju00 Judiciary Committee Senate Committee on the Judiciary. Ordered to be reported with an amendment favorably. Committee 2025-03-13 ssju00 Judiciary Committee Senate Read twice and referred to the Committee on the Judiciary. IntroReferral 2025-03-13 Introduced in Senate IntroReferral 10000 9 Library of Congress C001056 Sen. Cornyn, John [R-TX] John Cornyn R TX N B001277 Sen. Blumenthal, Richard [D-CT] Richard Blumenthal D CT 2025-03-13 True G000386 Sen. Grassley, Chuck [R-IA] Chuck Grassley R IA 2025-03-13 True D000563 Sen. Durbin, Richard J. [D-IL] Richard Durbin D IL J. 2025-03-13 True Health Administrative remedies 2025-04-07T15:31:56Z Civil actions and liability 2025-04-07T15:31:56Z Competition and antitrust 2025-04-07T15:31:56Z Consumer affairs 2025-04-07T15:31:56Z Drug safety, medical device, and laboratory regulation 2025-04-07T15:31:56Z Federal Trade Commission (FTC) 2025-04-07T15:31:56Z Health care costs and insurance 2025-04-07T15:31:56Z Inflation and prices 2025-04-07T15:31:56Z Intellectual property 2025-04-07T15:31:56Z Judicial review and appeals 2025-04-07T15:31:56Z Manufacturing 2025-04-07T15:31:56Z Prescription drugs 2025-04-07T15:31:56Z Health 2025-04-04T14:00:19Z

00 2025-03-13 Introduced in Senate 2026-01-30T17:34:23Z <p><strong>Drug Competition Enhancement Act </strong></p><p>This bill prohibits product hopping by drug manufacturers and authorizes the Federal Trade Commission (FTC) to enforce this prohibition.</p><p>Generally, <em>product&nbsp;hopping</em> describes a situation where, when the patents on a reference drug (or biological product) expire, the manufacturer switches to a follow-on product that is covered by a later-expiring patent. Under this bill, a <em>follow-on product</em> is a modified version of the reference drug that has an indication (what the drug is used for) that is identical or substantively similar to an indication of the reference drug.</p><p>The bill establishes a presumption that product hopping has occurred when a reference drug manufacturer, after receiving notice that the Food and Drug Administration has received an application to market a competing generic (or biosimilar) version, takes certain actions such as withdrawing the reference drug from the market and selling a follow-on product.</p><p>A drug manufacturer may rebut these presumptions by demonstrating that its conduct was not intended to limit competition.</p><p>The bill makes product hopping an unfair method of competition and provides for enforcement by the FTC. If the FTC has reason to believe a manufacturer has violated or is about to violate this prohibition on product hopping, the FTC may institute an administrative proceeding or bring suit in federal court to stop the manufacturer’s action and seek equitable remedies, including disgorgement of unjust profits or paying restitution to those harmed.&nbsp;</p>

Short Title(s) as Reported to Senate 103 2025-04-15T04:23:16Z S Senate Reported to Senate RS Display Title 45 2025-04-12T11:03:16Z Short Title(s) as Introduced 101 2025-04-03T13:38:22Z Introduced in Senate IS Official Title as Introduced 6 2025-04-03T13:33:29Z Introduced in Senate IS Reported to Senate 2025-04-10T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-119s1040rs/xml/BILLS-119s1040rs.xml Introduced in Senate 2025-03-13T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-119s1040is/xml/BILLS-119s1040is.xml 2025-04-10 Placed on Senate Legislative Calendar under General Orders. Calendar No. 43. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.